Myxoid liposarcoma: it's a hippo's world
Abstract Fused in sarcoma: DNA damage‐inducible transcript 3 protein (FUS:DDIT3) is a chimeric fusion oncoprotein present in 90% of human myxoid liposarcomas (MLS). The study by Trautmann et al in this issue of EMBO Molecular Medicine utilizes a drop‐out RNAi screen to establish hyperactive Yes‐asso...
| 出版年: | EMBO Molecular Medicine |
|---|---|
| 主要な著者: | , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Springer Nature
2019-04-01
|
| オンライン･アクセス: | https://doi.org/10.15252/emmm.201910470 |